Reported sales nil
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 4.68 crore in the quarter ended December 2022 as against net loss of Rs 0.33 crore during the previous quarter ended December 2021. There were no Sales reported in the quarter ended December 2022 as against Rs 17.43 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales017.43 -100 OPM %05.85 -PBDT-6.29-0.40 -1473 PBT-6.33-0.44 -1339 NP-4.68-0.33 -1318Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
